| Tadataka "Tachi" Yamada | |
|---|---|
in 2010 in Seattle |
|
| Born | June 5, 1945 Tokyo, Japan |
| Nationality | / |
| Alma mater | Stanford University, New York University |
| Occupation | physician, gastroenterologist, pharmaceutical executive |
| Known for | public health |
Tadataka "Tachi" Yamada, MD, KBE[1] (山田忠孝 Yamada Tadataka or “ターチ Taachi”, June 5, 1945– ), is the President of the Global Health Program at the Bill & Melinda Gates Foundation.[2] In this role, he leads the foundation’s efforts to help develop and deliver low-cost, life-saving health tools for the developing world.
Contents |
Yamada holds a bachelors degree in history from Stanford University, and MD from New York University
Before joining the foundation, Yamada served as Chairman of Research and Development and was a member of the Board of Directors at GlaxoSmithKline.[2]
Prior to that, he was Chairman of the Department of Internal Medicine at the University of Michigan Medical School[2] and Physician-in-Chief at the University of Michigan Medical Center.[2]
Yamada is a past president of the American Gastroenterological Association and the Association of American Physicians,[2] a master of the American College of Physicians,[2] and a member of the Institute of Medicine of the National Academy of Science in the United States and the Academy of Medical Sciences in the United Kingdom.[2]
On September 19, 2007 Yamada was named Knight Commander of the British Empire for his contribution to the British pharmaceutical industry and for his contributions to medical research in Britain.[1]
On February 14, 2011, Yamada announced that he would be stepping down in June 2011 from his five-year position as head of global health programs.[3]
In July 2007 Yamada was awarded an honorary doctorate by the University of East Anglia. In July 2008 he was awarded an honorary DSc by the University of Warwick.
He is a fellow of Imperial College London, and gave the last centenary lecture at Imperial College London in March 2008, which was chaired by Sir Richard Sykes.